Subject(s)
Hemochromatosis , Hemochromatosis/history , Hemochromatosis/diagnosis , Humans , Male , Saints/history , Medicine in the Arts/historySubject(s)
Hemochromatosis , Ferritins/history , Ferritins/metabolism , Hemochromatosis/genetics , Hemochromatosis/history , Hemochromatosis/physiopathology , Hemochromatosis/therapy , History, 19th Century , History, 20th Century , Humans , Medical Illustration/history , Phlebotomy/history , Transferrin/history , Transferrin/metabolismABSTRACT
Hereditary hemochromatosis is caused by a potentially lethal recessive gene (HFE, C282Y allele) that increases iron absorption and reaches polymorphic levels in northern European populations. Because persons carrying the allele absorb iron more readily than do noncarriers, it has often been suggested that HFE is an adaptation to anemia. We hypothesize positive selection for HFE began during or after the European Neolithic with the adoption of an iron-deficient high-grain and dairying diet and consequent anemia, a finding confirmed in Neolithic and later European skeletons. HFE frequency compared with rate of lactase persistence in Eurasia yields a positive linear correlation coefficient of 0.86. We suggest this is just one of many mutations that became common after the adoption of agriculture.
Subject(s)
Adaptation, Biological/genetics , Hemochromatosis/genetics , Histocompatibility Antigens Class I/genetics , Membrane Proteins/genetics , White People/genetics , Anemia/genetics , Diet/history , Gene Frequency , Hemochromatosis/history , Hemochromatosis Protein , Histocompatibility Antigens Class I/history , History, Ancient , Humans , Membrane Proteins/history , White People/historySubject(s)
Hemochromatosis/physiopathology , Iron Overload/physiopathology , Iron/metabolism , Hemochromatosis/history , Hemochromatosis/therapy , Hemochromatosis Protein , Hepcidins/physiology , Histocompatibility Antigens Class I/physiology , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , Homeostasis/physiology , Humans , Iron Overload/history , Iron Overload/therapy , Membrane Proteins/physiologyABSTRACT
Hereditary hemochromatosis (HH) is a common inherited disorder of iron metabolism affecting about 1 in 250 individuals. HH results in an increased absorption of iron at the baso-lateral surface of the enterocyte with aberrant regulation of ferroportin-mediated transfer of iron in turn brought on by a decrease in circulating hepcidin. The medical literature describes a colorful history of HH with important contributions from faculty at Saint Louis University.
Subject(s)
Hemochromatosis/history , Histocompatibility Antigens Class I/history , Membrane Proteins/history , Hemochromatosis/genetics , Hemochromatosis/pathology , Hemochromatosis Protein , Histocompatibility Antigens Class I/genetics , History, 20th Century , Humans , Membrane Proteins/genetics , MissouriABSTRACT
BACKGROUND: Mitochondrial DNA (mtDNA) and Y-DNA analysis have been widely used to predict ancestral origin. Genetic anthropologists predict that human civilizations may have originated in central Africa one to two million years previously. Primary iron overload is not a common diagnosis among indigenous people of northern Africa, but hereditary hemochromatosis is present in approximately one in 200 people in northern Europe. MtDNA analysis has the potential to determine whether contemporary hemochromatosis patients have an ancient ancestral linkage. METHODS: DNA was obtained from buccal smears for mtDNA and Y-DNA analysis. Y-DNA analysis included examination of 20 short tandem repeat markers on the Y chromosome. Analysis of mtDNA involved sequencing of the HVR-1 genetic sequence (nucleotides 16001 to 16520) and was compared with the Cambridge Reference Sequence. MtDNA ancestral haplotypes were predicted from the analysis of the HVR-1 sequence. RESULTS: Twenty-six male C282Y homozygotes were studied. There were 28 polymorphisms present in the HVR-1 sequence of these participants. The most common polymorphism was present at position 16519 in 15 participants and at position 16311 in eight participants. There were 12 different ancestral haplotypes predicted by mtDNA analysis, with the K haplotype being present in five participants. Y-DNA analysis revealed eight different haplotypes, with R1b being found in 11 of the 26 participants. CONCLUSION: Analysis of mtDNA and Y-DNA in 26 hemochromatosis patients suggested that they did not all originate from the same ancestral tribe in Africa. These findings were consistent with the theory that the original hemochromatosis mutation occurred after migration of these ancestral people to central Europe, possibly 4000 years previously.
Subject(s)
Chromosomes, Human, Y/genetics , DNA, Mitochondrial/analysis , Hemochromatosis/genetics , Africa , Canada , Emigration and Immigration/history , Europe , Genetic Predisposition to Disease , Genetics, Population , Genome-Wide Association Study , Hemochromatosis/history , History, Ancient , Homozygote , Humans , Male , Phylogeography , Polymorphism, Genetic , Population Dynamics/history , Selection, Genetic , Sequence Analysis, DNA , Sex Chromosome AberrationsABSTRACT
UNLABELLED: The HLA-related hemochromatosis mutation C282Y is thought to have originated in Ireland in a person with HLA-A3-B14 and was spread by Vikings. Irish people with two HLA-A3 alleles had a high risk of hemochromatosis. In this study, from west Sweden, we wanted to test these hypotheses. METHODS: HFE mutations in controls, bone marrow donors with HLA-A3/A3 and patients with hemochromatosis. HLA haplotypes, extended haplotype analysis and pedigree studies. RESULTS: The allelic C282Y frequency 0.04, (CI 0.01-0.07) was lower (P < 0.001) in Sweden than in Ireland 0.10 (CI 0.08-0.11), and Swedish bone marrow donors with HLA-A3/A3 (n = 77) had a low risk of hemochromatosis. HLA haplotypes available from 239/262 (91.5%) proband patients homozygous for C282Y showed a dominance of A3-B7 and A3-B14 both in linkage disequilibrium with controls (P < 0.001). Pedigree studies extended into the 17th century supported a local founder effect of A3-B14 in the county of Bohuslän. The A3-B14 haplotype may well be the original and A3-B7 the result of centromeric recombinations. The haplotype diversity and recombination events were not different from a Celtic series. These findings do not support the hypothesis of the C282Y mutation being of an Irish Celtic origin. CONCLUSIONS: The C282Y frequency shows a west to east decline from Ireland through the north of Europe. Vikings may have been involved in the spread of C282Y, but the mutation is probably older and may have been spread in Europe by earlier seafarers.
Subject(s)
Founder Effect , Hemochromatosis/genetics , Mutation, Missense , Case-Control Studies , Europe , Gene Frequency , Genetics, Population/methods , Genotype , HLA-A3 Antigen/genetics , Haplotypes , Hemochromatosis/history , History, Medieval , Humans , Ireland , Linkage Disequilibrium , Pedigree , SwedenABSTRACT
Australia has had a proud and enviable record of seminal contributions to hepatology, with many contributors. Thus, any attempt to summarize these contributions ab initio in a brief review article is a significant challenge, primarily because it is so easy to overlook or underestimate particular aspects. In this article, I have confined my comments primarily to the areas where the contributions have had a significant global impact and have clearly been recognized internationally. This means that many worthwhile Australian additions will be omitted if there was less apparent international impact. The first significant interest in liver disease in Australia was from the Melbourne group at the Walter and Eliza Hall Institute (WEHI) and Royal Melbourne Hospital, leading to seminal contributions to the description, diagnosis, aetiopathogenesis and therapy of autoimmune hepatitis and primary biliary cirrhosis. Others from Royal Prince Alfred Hospital in Sydney contributed substantially to the effects of immunosuppression of autoimmune hepatitis and to early descriptions of primary sclerosing cholangitis. Other areas where Australians have contributed significantly include steatohepatitis, iron metabolism (and in particular hemochromatosis), viral hepatitis (both at the molecular and clinical level), portal hypertension, and transplant immunology. The remarkable contribution of Professor Dame Sheila Sherlock to Australian hepatology is also summarized.
Subject(s)
Biomedical Research/history , Liver Diseases/history , Liver Transplantation/history , Ascites/history , Ascites/surgery , Australia , Autoimmunity , Carcinoma, Hepatocellular/history , Carcinoma, Hepatocellular/surgery , Fatty Liver/history , Fatty Liver/surgery , Hemochromatosis/history , Hemochromatosis/surgery , Hepatitis, Viral, Human/history , Hepatitis, Viral, Human/surgery , History, 20th Century , History, 21st Century , Humans , Hypertension, Portal/history , Hypertension, Portal/surgery , Liver/metabolism , Liver Diseases/diagnosis , Liver Diseases/immunology , Liver Diseases/metabolism , Liver Diseases/surgery , Liver Neoplasms/history , Liver Neoplasms/surgery , Treatment OutcomeABSTRACT
BACKGROUND: The hemochromatosis mutation, C282Y of the HFE gene, seems to have originated from a single event which once occurred in a person living in the north west of Europe carrying human leukocyte antigen (HLA)-A3-B7. In descendants of this ancestor also other haplotypes appear probably caused by local recombinations and founder effects. The background of these associations is unknown. Isolated river valley populations may be fruitful for the mapping of genetic disorders such as hemochromatosis. In this study, we try to test this hypothesis in a study from central Sweden where the haplotyope A1-B8 was common. METHODS: HLA haplotypes and HFE mutations were studied in hemochromatosis patients with present or past parental origin in a sparsely populated (1/km(2)) rural district (n = 8366 in the year of 2005), in central Sweden. Pedigrees were constructed from the Swedish church book registry. Extended haplotypes were studied to evaluate origin of recombinations. RESULTS: There were 87 original probands, 36 females and 51 males identified during 30 yr, of whom 86% carried C282Y/C282Y and 14% C282Y/H63D. Of 32 different HLA haplotypes A1-B8 was the most common (34%), followed by A3-B7 (16%), both in strong linkage disequilibrium with controls, (P < 0.001). Twenty-nine different families with A1-B8 had a common founder origin 15 generations ago in small bottleneck populations of the late 16th century. A second A1-B8 founder born 1655 was of Norwegian origin. Most of the A3 carriers (n = 26) had a common founder origin 16 generations ago in an even smaller nearby river valley. A fourth founder family carrying HLA-A2 seems to have originated from a recombination along the descendant lines from the A3 ancestor supported by extended haplotype studies. A1-haplotypes with alleles at the B locus different from B8 had a similar recombination origin as HLA-A2 alleles and a common founder origin 11 generations ago. The intergenerational time interval averaged 35.5 +/- 7.9 yr in men and 31.9 +/- 5.9 in females. CONCLUSIONS: River valley populations may contain HLA haplotypes reflecting their demographic history. This study has demonstrated that the resistance against recombinations between HLA-A and HFE make HLA haplotypes excellent markers for population movements. Founder effects and genetic drift from bottleneck populations (surviving the plague?) may explain the commonness of the mutation in central Scandinavia. The intergenerational time difference >30 yr was greater than expected and means that the age of the original mutation may be underestimated.
Subject(s)
Founder Effect , HLA Antigens , Haplotypes , Hemochromatosis/genetics , Histocompatibility Antigens Class I/genetics , Membrane Proteins/genetics , Pedigree , Female , Genetics, Population , Hemochromatosis/epidemiology , Hemochromatosis/history , Hemochromatosis Protein , History, 17th Century , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Male , Point Mutation , Rivers , SwedenSubject(s)
Gastroenterology/history , Hemochromatosis/history , England , Europe , History, 20th Century , Humans , United StatesSubject(s)
Humans , Male , Adult , Hemochromatosis/complications , Hemochromatosis/diagnosis , Hemochromatosis/etiology , Hemochromatosis/genetics , Hemochromatosis/history , Hemochromatosis/prevention & control , Hemochromatosis/therapy , Iron Overload/diagnosis , Iron Overload/etiology , Iron Overload/therapy , Liver/pathology , Biopsy , Blood Chemical Analysis , Diagnosis, Differential , Early Diagnosis , Genetic Markers , Liver Diseases, Alcoholic , Porphyria Cutanea Tarda , Iron/metabolism , Genes, MHC Class ISubject(s)
Humans , Male , Adult , Hemochromatosis/complications , Hemochromatosis/diagnosis , Hemochromatosis/etiology , Hemochromatosis/genetics , Hemochromatosis/history , Hemochromatosis/prevention & control , Hemochromatosis/therapy , Iron Overload/diagnosis , Iron Overload/etiology , Iron Overload/therapy , Blood Chemical Analysis , Biopsy , Diagnosis, Differential , Early Diagnosis , Genes, MHC Class I , Liver Diseases, Alcoholic , Iron/metabolism , Liver/pathology , Genetic Markers , Porphyria Cutanea TardaSubject(s)
Hemochromatosis/history , Histocompatibility Antigens Class I/history , Membrane Proteins/history , Gastroenterology/history , Genetics/history , Hemochromatosis/genetics , Hemochromatosis Protein , Histocompatibility Antigens Class I/genetics , History, 20th Century , Humans , Membrane Proteins/genetics , MutationSubject(s)
Iron/history , Anemia, Hypochromic/diet therapy , Anemia, Hypochromic/etiology , Anemia, Hypochromic/history , Hemochromatosis/history , Hemochromatosis/metabolism , Hemochromatosis/physiopathology , History, 16th Century , History, 17th Century , History, 20th Century , History, 21st Century , History, Ancient , Iron/metabolism , Iron DeficienciesSubject(s)
Humans , Male , Adult , Middle Aged , Erythropoietin/therapeutic use , Hemochromatosis/diagnosis , Hemochromatosis/etiology , Hemochromatosis/genetics , Hemochromatosis/history , Hemochromatosis/physiopathology , Hemochromatosis/therapy , Hepatomegaly , Iron Overload/complications , Iron Overload/physiopathology , Phlebotomy/statistics & numerical data , Amenorrhea , Diabetes Mellitus/complications , Diabetes Mellitus/mortality , Fibrosis , Hyperpigmentation , Heart Failure/mortality , Renal Insufficiency, Chronic/therapy , Joint Diseases/complications , Liver Neoplasms/mortality , Sexual Dysfunction, PhysiologicalSubject(s)
Humans , Male , Adult , Middle Aged , Hemochromatosis/history , Hemochromatosis/etiology , Hemochromatosis/genetics , Hemochromatosis/diagnosis , Hemochromatosis/therapy , Hemochromatosis/physiopathology , Iron Overload/complications , Iron Overload/physiopathology , Hepatomegaly , Phlebotomy/statistics & numerical data , Erythropoietin/therapeutic use , Liver Neoplasms/mortality , Diabetes Mellitus/complications , Diabetes Mellitus/mortality , Hyperpigmentation , Heart Failure/mortality , Joint Diseases/complications , Sexual Dysfunction, Physiological , Amenorrhea , Renal Insufficiency, Chronic/therapy , FibrosisABSTRACT
Dr. Wagner's description of an advanced macronodular cirrhosis is compatible with end-stage liver disease due to a variety of causes. An alcoholic etiology seems more probable than chronic viral hepatitis since such a diagnosis might also account for the chronic pancreatitis, unless it was related to the cholelithiasis. However, Dr. Wagner's description favors a diagnosis of biliary pigment sludge related to hemolysis. Furthermore, the controversy over the extent of Beethoven's alcohol consumption and the absence of mention of pancreatic calcification weakens the case for an alcoholic etiology. On the other hand, Dr. Wagner's emphasis of bluish-green pigmentation of the liver, blackish pigmentation of the spleen, and an arteropathy of the hepatic vessels suggests the probability of hemochromatosis, which diagnosis is also in keeping with Beethoven's medical history. In this regard the composer's history of recurrent obscure abdominal pain, commencing in his third decade, is especially in keeping with hemochromatosis. As many as a third of patients present with recurrent abdominal pain, and eventually up to 40% of cases develop significant abdominal pain in the course of their disease. While some of these cases of abdominal pain have been attributed to hepatoma, ascites, pancreatitis, perisplenitis, or diabetic neuropathy, the majority remain ill-defined (32). Even so, the diagnosis of hemochromatosis remains unproved in the absence of a histological examination and measurement of hepatic iron concentration. It is proposed that the combined additive, toxic effects of alcohol and iron were the most likely cause of Beethoven's cirrhosis.